Updates on the biology of chronic lymphocytic leukemia: introductory editorial

E Ten Hacken, B Eichhorst - Seminars in Hematology, 2024 - Elsevier
Chronic lymphocytic leukemia (CLL) displays a highly variable clinical course reflecting
numerous layers of heterogeneity stemming from the multiple factors implicated in its …

[PDF][PDF] Dysregulated MicroRNAs in Chronic Lymphocytic Leukemia

O Mesaros, S Veres, M Onciul, E Matei, L Jimbu… - Cureus, 2024 - cureus.com
MiRNAs are a class of non-coding RNAs acting as gene expression regulators by
modulating the lifespan of messenger RNA. Commonly referred to as the most frequent …

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study

E Nano, F Reggiani, AA Amaro, P Monti… - Non-coding …, 2024 - pmc.ncbi.nlm.nih.gov
A “watch and wait” strategy, delaying treatment until active disease manifests, is adopted for
most CLL cases; however, prognostic models incorporating biomarkers have shown to be …

Dysregulated MicroRNAs in Chronic Lymphocytic Leukemia

M Oana, V Stefana, O Madalina, M Emilia, J Laura… - Cureus, 2024 - search.proquest.com
MiRNAs are a class of non-coding RNAs acting as gene expression regulators by
modulating the lifespan of messenger RNA. Commonly referred to as the most frequent …